INMB

INMB

USD

INmune Bio Inc. Common stock

$1.720-0.050 (-2.825%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.770

Máximo

$1.790

Mínimo

$1.710

Volumen

0.26M

Fundamentos de la Empresa

Capitalización de Mercado

45.7M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.61M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.71Actual $1.720Máximo $11.64

Noticias Relacionadas

GlobeNewswire

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient's innate

Ver más
GlobeNewswire

INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025

Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, Oct. 23, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), INmune Bio Inc. (NASDAQ:INMB), a

Ver más
GlobeNewswire

INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025

Boca Raton, FL, Oct. 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:INMB), a clinical-stage inflammation and immunology company, today announces that David Moss, Chief Executive Officer will participate in a

Ver más
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.